IP Roundup | GenomeWeb

IP Roundup

Premium

Agilent Technologies has received US Patent No. 7,534,561, “Nucleic acid array in situ fabrication methods and arrays produced using the same.” The patent claims methods and devices for producing nucleic acid arrays using in situ nucleic acid array synthesis protocols. According to the patent’s abstract, control probes are produced in columns on the arrays, and the probes are selected according to a particular protocol. An ‘all-bases-all-layers’ probe set is also produced in at least one column on the arrays.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.